Clinical Trials Directory

Trials / Completed

CompletedNCT05390229

Screening Contrast-enhanced Mammography

Comparison of the Performance of Diagnostic Contrast-enhanced Mammography and Magnetic Resonance Imaging for Suspicious Breast Lesion at Screening

Status
Completed
Phase
Study type
Observational
Enrollment
231 (actual)
Sponsor
CHU de Quebec-Universite Laval · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The main objective of this study is to compare the diagnostic performance of two diagnostic methods, namely CESM and MRI, in the evaluation of a lesion suspicious of breast cancer in 300 Quebec women referred for the investigation of breast cancer. breast lesion suspected of cancer. All suspicious lesions will be evaluated by these two diagnostic imaging and by TNM. Then, radiologists will respectively interpret diagnostic imaging, without knowing the result of the other imaging in parallel with the study. The sensitivity, specificity, positive predictive value and negative predictive value for his diagnostic imaging will then be determined. Histopathological confirmation by biopsy or surgery will be used as a standard value.

Conditions

Timeline

Start date
2018-12-12
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2022-05-25
Last updated
2026-03-19

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05390229. Inclusion in this directory is not an endorsement.